Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden.
about
Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling.Ligand-targeted theranostic nanomedicines against cancerDisruption of TWIST1-RELA binding by mutation and competitive inhibition to validate the TWIST1 WR domain as a therapeutic target.Development of mesoporous silica-based nanoparticles with controlled release capability for cancer therapy.Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer.Biomimetic synthesis of proline-derivative templated mesoporous silica for increasing the brain distribution of diazepam and improving the pharmacodynamics of nimesulide.Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer.Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer.Synthesis, Physicochemical Characterization, and Cytotoxicity Assessment of CeO2 Nanoparticles with Different Morphologies
P2860
Q33635355-91F9B52F-8174-414F-973E-336BDFAFF077Q34545399-8AE10019-C3A5-45C7-BEF6-F57D1DDF706EQ35895637-95B38308-2895-488F-B767-D08F241370B7Q36304712-B34EB8CE-C463-4B5E-9FD4-D01A3DC7129DQ36328315-9FCAEF7E-2CFA-4F06-B73D-9900ED9164ACQ37500100-7E6D14B4-AC6F-4A51-AEE9-681B99652B0FQ38665073-84C12CE3-60DD-4091-8DE0-EB6D881EFE97Q47267991-646DC0CA-5941-417E-82C5-A340ABC429CAQ48256868-9DC8176C-E2B2-4FFF-9F52-0A4123528FBDQ55228197-10926A50-6BBC-4312-AA56-C3AE5C4190B0Q58232226-28CB83A8-6BC3-4D4C-9B79-201BE30C1D68
P2860
Mesoporous silica nanoparticle delivery of chemically modified siRNA against TWIST1 leads to reduced tumor burden.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Mesoporous silica nanoparticle ...... leads to reduced tumor burden.
@ast
Mesoporous silica nanoparticle ...... leads to reduced tumor burden.
@en
type
label
Mesoporous silica nanoparticle ...... leads to reduced tumor burden.
@ast
Mesoporous silica nanoparticle ...... leads to reduced tumor burden.
@en
prefLabel
Mesoporous silica nanoparticle ...... leads to reduced tumor burden.
@ast
Mesoporous silica nanoparticle ...... leads to reduced tumor burden.
@en
P2093
P2860
P1476
Mesoporous silica nanoparticle ...... leads to reduced tumor burden
@en
P2093
Cai M Roberts
Fuyuhiko Tamanoi
James Finlay
Jeffrey I Zink
P2860
P304
P356
10.1016/J.NANO.2015.05.011
P577
2015-06-24T00:00:00Z